Insulin pump use during hospitalization may improve glycemic outcomes and reduce length of stay for people with diabetes, ...

Early proof-of-concept study showed that a patch pump with integrated glucose sensing at the site of insulin delivery can ...

Tandem Diabetes Care issued an urgent medical device correction to upgrade the software of its Tandem Mobi insulin pumps that ...

Allowing patients to keep using their personal diabetes technology during hospitalization improves glycemic control and reduces length of stay.

The FDA cleared an automated insulin delivery system for use by pregnant women with type 1 diabetes, according to an industry ...

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully ...

Including continuous glucose monitors (CGMs) and insulin pumps in the next round of Medicare’s competitive bidding program ...

The US Food and Drug Administration (FDA) has issued a Class I recall for the t:connect mobile app on iOS, which is used to monitor and control the t:slim X2 insulin pump used by people with diabetes.

Small internal tears in Omnipod 5 insulin pump pods could lead to underdosing ...